Biotech Law 
Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting – msnbc.com
unless so required by applicable law. The Group’s business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. Active Biotech is obligated to publish the information contained in …
Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting – Market Wire
unless so required by applicable law. The Group’s business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. Active Biotech is obligated to publish the information contained in …
Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting – SYS-CON Media
unless so required by applicable law. The Group’s business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. Active Biotech is obligated to publish the information contained in …
NERIUM BIOTECHNOLOGY INC – 10-Q – Management’s Interim Discussion and Analysis of Financial Condition and Results of Operations – TMCnet
Overview Nerium Biotechnology, Inc. (“Nerium” or the “Company”) is … as required by Canadian securities law. Based on that evaluation, the CEO and CFO have concluded that, as at March 31, 2012, the disclosure controls and procedures were …
Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting – Phramalive.com
Puma Biotechnology, Inc. is a development stage biopharmaceutical … The Company assumes no obligation to update these forward-looking statements, except as required by law.
Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting – Yahoo Finance
Puma Biotechnology, Inc. (OTCBB … The Company assumes no obligation to update these forward-looking statements, except as required by law.
Expert calls for expedition of the implementation of Biosafety Law – GhanaHomePage
The Biosafety Act, 831, 2011 will enable Ghana to regulate for responsible development, handling and use of genetically modified organisms (GMO) derived from biotechnology … noted that the implementation of the law would help to establish a transparent …
Survey Finds That Many U.S. Consumers Have Favorable Impression of Plant and Animal Biotechnology – jdsupra.com
Only 24% of respondents believed additional information should be required on food labels, with only 3% suggesting that the additional information that was needed on labels related to biotechnology. Published In: Administrative Law Updates, Science …
Q&A With Duane Morris’ Vicki Norton – site.law360.com
Norton, Ph.D., is a partner in Duane Morris LLP’s San Diego office, where she co-chairs the life sciences and biotechnology division of its intellectual property practice group. She practices in the area of IP law with a focus on biotechnology … Continue reading
Mercury News editorial: Bond measures will help local schools educate students for 21st century – San Jose Mercury News
Many district buildings are decades old, built mostly before high-tech equipment was needed to train students for four-year colleges and for careers in fields like nursing and biotech … margin required by law, each new measure will be …
